|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1992-10-30
|
|
pubmed:abstractText |
A phase II study of etoposide (VP 16) and carboplatin (CBDCA) was performed in patients with metastatic neuroblastoma (NB). The aim of the study was to find an alternative treatment for induction with different toxicities than the VP 16/cisplatin (CDDP) combination.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1592-601
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:1403039-Adolescent,
pubmed-meshheading:1403039-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1403039-Carboplatin,
pubmed-meshheading:1403039-Child,
pubmed-meshheading:1403039-Child, Preschool,
pubmed-meshheading:1403039-Drug Administration Schedule,
pubmed-meshheading:1403039-Etoposide,
pubmed-meshheading:1403039-Female,
pubmed-meshheading:1403039-Humans,
pubmed-meshheading:1403039-Infant,
pubmed-meshheading:1403039-Male,
pubmed-meshheading:1403039-Neuroblastoma,
pubmed-meshheading:1403039-Treatment Outcome
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study.
|
|
pubmed:affiliation |
Department of Pediatric Oncology, Centre Léon Bérard, Lyon, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
